Pinealon 20mg × 10 vials

A synthetic short peptide studied for neuropeptide research, pineal-gland-related pathways, cellular aging models, cognitive-function research, circadian rhythm mechanisms, oxidative stress response, and broader neuroendocrine regulation protocols.

Product Overview

Compound: Pinealon
Strength: 20 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 20 mg
BAC water: 2 mL
Amount per unit: 100 mcg per unit

Research Dose

Protocol dependent.

Notes

Pinealon is described as a synthetic tripeptide studied in relation to neuroendocrine regulation, pineal-gland-associated pathways, cellular stress response, and nervous-system function.

Research literature has examined Pinealon in connection with cognitive-function models, neuronal protection pathways, oxidative stress modulation, age-associated cellular changes, and circadian rhythm-related mechanisms.

Pinealon is often discussed within bioregulatory peptide research, but it should not be treated as a standard therapeutic product or consumer wellness protocol.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.